RECURRENT GLIOMA
Clinical trials for RECURRENT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Four-in-One antibody takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called GNC-039 in about 60 people with brain tumors (glioma) or other solid cancers that have come back or spread. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants must have tr…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Engineered immune cells take on deadly brain cancer
Disease control Recruiting nowThis early-phase study tests a new treatment called CARv3-TEAM-E T cells for people with glioblastoma, a fast-growing brain cancer. The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack the tumor. The main goal is to find the safest d…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE1 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New hope for brain cancer: targeted pill shrinks tumors in early trial
Disease control Recruiting nowThis study tests a pill called erdafitinib in 30 adults with a specific type of brain tumor (glioma) that has returned or is growing. The tumor must have a certain gene change (FGFR-TACC fusion). The drug blocks a faulty protein that helps tumors grow, aiming to slow or shrink th…
Matched conditions: RECURRENT GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Brain tumor care goes digital: app aims to bridge access gap
Knowledge-focused Recruiting nowThis study tests whether a mobile app can help people with glioma (a type of brain tumor) receive treatment and monitoring at home instead of traveling to a specialist center. The goal is to see if this digital approach is practical and acceptable for patients, especially those w…
Matched conditions: RECURRENT GLIOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 03:05 UTC